Tremendous successes have been achieved in treating and caring for people living with HIV and in developing HIV prevention technologies such as pre-exposure prophylaxis (PrEP) and post-exposure ...
A clinical trial sponsored by the National Institutes of Health (NIH) has launched to examine the safety and acceptability of ...
A flexible silicone ring that slowly releases antiretrovirals is one of just two long-acting HIV prevention products ...
This means you still have the HIV infection when early symptoms are gone. It’s important to get treatment for HIV to help ...
Opens in a new tab or window Real-world data presented at the 2024 IDWeek annual meeting in Los Angeles highlighted the ...
A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...
For years, a preventive treatment that can significantly decrease the risk of contracting HIV has been available in Nova ...
Kind Clinic’s “Blue Dress Bar Crawl,” a fundraiser for the clinic and its HIV prevention efforts, returns for its fourth year ...
A recent study reveals that nearly 20% of United States physicians treating HIV patients plan to leave or reduce their ...
In a recent study of more than 200 individuals, Chen and colleagues used GPS data to identify venue-based networks to provide HIV prevention interventions and identify more potentially affected ...
Marc Meachem, head of U.S. External Affairs at ViiV Healthcare, highlights factors that contribute to the disproportionate ...
Such use of antiretrovirals to prevent HIV infection is called pre-exposure prophylaxis (PrEP). The most widely used form of PrEP is a daily HIV prevention pill that contains the antiretrovirals ...